Even 'safe' medications need to be administered with care

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Lutwak, Nancy ^a   Howland, Mary Ann ^b   Gambetta, Rosemarie ^c   Dill, Curt ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BELLEVUE HOSPITAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIDOCAINE;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; ATAXIA; CARDIOMYOPATHY; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; DIPLOPIA; DRUG ABSORPTION; DRUG CLEARANCE; DRUG METABOLISM; FIRST PASS EFFECT; HEART EJECTION FRACTION; HUMAN; LIVER BLOOD FLOW; MALE; MEDICAL HISTORY; NEUROTOXICITY; PATIENT CARE; PATIENT SAFETY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 84872701293     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2012-006204     Document Type: Article

References (22)

1. Berlin CM Jr. (Chairperson Committee on Drugs-American Academy of Pediatrics). Alternate routes of drug administration-advantages and disadvantages (subject review). Pediatrics 1997;100:143-52.
2. Lev R, Rosen P. Prophylactic lidocaine use preintubation:a review. J Emerg Med 1994;12:499-506.
3. Lipkind GM, Fozzard HA. Molecular modeling of local anesthetic drug binding by voltage-gated sodium channels. Mol Pharmacol 2005;68:1611-22.
4. Flomenbaum NE, Howland MA, Goldfrank LR, et al. eds.Goldfrank's Toxicologic Emergencies, 8th edn. New York, NY, McGraw-Hill, 2006:560-5
5. Taliani G, Ducca F, Lecce R, et al. Hepatic lidocaine metabolism in chronic hepatitis C virus hepatitis with or without steatosis. Hepatology 1995;21:1760-1.
6. Zaman N, Tam YK, Jewell LD, et al. Effects of intravenous lipid as a source of energy in parenteral nutrition associated hepatic dysfunction and lidocaine elimination: a study using isolated rat liver perfusion. Biopharm Drug Dispos 1997;18:803-19.
7. Munoz AE, Miguez C, Rubio M, et al. Lidocaine and monoethylglycinexylide serum determinations to analyze liver function of cirrhotic patients after oral administration. Dig Dis and Sci 1999;44:789-95.
8. Oellerich M, Armstrong VW. The MEGX Test: a tool for the real-time assessment of hepatic function. Ther Drug Monit 2001;23:81-92.
9. Bradley SE, Ingelfinger FJ, Bradley GP. Hepatic circulation in cirrhosis of the liver. Circulation 1952;5:419-29.
10. Sloss A, Kubler P. Prescribing in liver disease. Aust Prescriber 2009;32:32-5.
11. Verbeeck RK. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol 2008;64:1147-61.
12. Perucca E, Richens A. Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients. Br J Clin Pharmacol 1979;8:21-31.
13. Shiffman ML, Luketic VA, Sanyal AJ, et al. Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease. Therapeutic Drug Monitoring- Proceedings of the Fourth International Congress of Therapeutic Drug Monitoring and Clinical Toxicology 1996;18:372-7.
14. Bibi Z. Review-role of cytochrome P450 in drug interactions. Nutr Metab 2008;5:27.
15. Rao RB, Ely SF, Hoffman RS. Deaths related to liposuction. N Engl J Med 1999;340:1471-5.
16. King CR. The safe uses of lidocaine during bronchoscopy. EndoNurse 2005. http://www.endonurse.com/.../the-safe-uses-of-lidocaine-during-bronchoscopy. aspx (accessed 8 January 2012).
17. Mehra P, Caiazzo A, Maloney P. Lidocaine toxicity. Anesth Prog 1998;45:38-41.
18. Perney P, Blanc F, Mourad G, P, et al. Transitory ataxia related to topically administered lidocaine. Ann Pharmacother 2004;38:828-30.
19. Horowitz J, Almog Y, Wolf A, et al. Opthalmic complications of dental anesthesia: three new cases. J Neuro-opthalmol 2005;25:95-100.
20. Kawamata M, Omote K, Namiki A. Bilateral interpleural injection of lidocaine after bilateral lung surgery through median sternotomy in four patients. Anesth Analg 1992;75:1046-9.
21. Sharma SC, Rama PR, Miller GL, et al. Systemic absorption and toxicity from topically administered lidocaine during transesophageal echocardiography. J Am Soc Echocard 1996;9:710-1.
22. Lidocaine ointment official FDA information, side effects and uses. http